Janet Rehnquist
Board Member
NRX Pharmaceuticals, Inc. (NRXP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Janet Rehnquist
Janet Rehnquist is recorded as Board Member at NRX Pharmaceuticals, Inc. (NRXP). NRX Pharmaceuticals, Inc. reported in an 8-K filed January 22, 2025 that Janet Rehnquist resigned as Board, effective January 7, 2025. NRX Pharmaceuticals, Inc. reported in an 8-K filed January 14, 2025 that Janet Rehnquist resigned as member of the Board of Directors, effective January 7, 2025. NRX Pharmaceuticals, Inc. reported in an 8-K filed December 29, 2023 that Janet Rehnquist was appointed Class II member of the Company's board of directors, effective December 28, 2023.
“Mr. Taylor was appointed to fill the seat vacated as a result of the resignation from the Board of Janet Rehnquist on January 7, 2025.”
“On January 7, 2025, Janet Rehnquist resigned as a member of the Board of Directors (“Board”) of NRx Pharmaceuticals, Inc. (the “Company”), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-28–present
-
2023-12-28–2025-01-07
-
Start not stated–2025-01-07
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at NRX Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Jonathan C. Javitt CEO, Chairman, Board Member
- Jonathan Javitt CEO, Chairman
- Stephen Willard CEO
- Bennett Kim CFO, Board Member
- Dr. Seth Van Voorhees CFO
- Ira Strassberg CFO
- Michael Abrams CFO
- William Fricker CFO
- Joseph Casper COO
- Joseph M. Casper COO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.